Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Tensile force exerted by suture during renorrhaphy using current techniques.

Zanghi J, Boyer J, Martinez C, Patel A, Petit C, Siegert J, Nguyen T.

J Robot Surg. 2019 Jul 12. doi: 10.1007/s11701-019-00999-y. [Epub ahead of print]

PMID:
31301022
2.

Enantio- and Diastereoselective Synthesis of Functionalized Carbocycles by Cu-Catalyzed Borylative Cyclization of Alkynes with Ketones.

Zanghi JM, Liu S, Meek SJ.

Org Lett. 2019 Jul 5;21(13):5172-5177. doi: 10.1021/acs.orglett.9b01769. Epub 2019 Jun 14.

PMID:
31199654
3.

A useful model to compare human and mouse growth hormone gene chromosomal structure, expression and regulation, and immune tolerance of human growth hormone analogues.

Cattini PA, Bock ME, Jin Y, Zanghi JA, Vakili H.

Growth Horm IGF Res. 2018 Oct - Dec;42-43:58-65. doi: 10.1016/j.ghir.2018.09.001. Epub 2018 Sep 12. Review.

PMID:
30227383
4.

Enantio- and Diastereoselective Synthesis of Hydroxy Bis(boronates) via Cu-Catalyzed Tandem Borylation/1,2-Addition.

Green JC, Joannou MV, Murray SA, Zanghi JM, Meek SJ.

ACS Catal. 2017;7(7):4441-4445. doi: 10.1021/acscatal.7b01123. Epub 2017 May 25.

5.

Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis.

Garcia S, Hartkamp LM, Malvar-Fernandez B, van Es IE, Lin H, Wong J, Long L, Zanghi JA, Rankin AL, Masteller EL, Wong BR, Radstake TR, Tak PP, Reedquist KA.

Arthritis Res Ther. 2016 Mar 31;18:75. doi: 10.1186/s13075-016-0973-6.

6.

A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors.

Tolcher AW, Papadopoulos KP, Patnaik A, Wilson K, Thayer S, Zanghi J, Gemo AT, Kavanaugh WM, Keer HN, LoRusso PM.

Ann Oncol. 2016 Mar;27(3):526-32. doi: 10.1093/annonc/mdv591. Epub 2015 Dec 8.

PMID:
26646757
7.

Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer.

Harding TC, Long L, Palencia S, Zhang H, Sadra A, Hestir K, Patil N, Levin A, Hsu AW, Charych D, Brennan T, Zanghi J, Halenbeck R, Marshall SA, Qin M, Doberstein SK, Hollenbaugh D, Kavanaugh WM, Williams LT, Baker KP.

Sci Transl Med. 2013 Mar 27;5(178):178ra39. doi: 10.1126/scitranslmed.3005414.

8.

Regulated overexpression of the survival factor bcl-2 in CHO cells increases viable cell density in batch culture and decreases DNA release in extended fixed-bed cultivation.

Fussenegger M, Fassnacht D, Schwartz R, Zanghi JA, Graf M, Bailey JE, Pörtner R.

Cytotechnology. 2000 Jan;32(1):45-61. doi: 10.1023/A:1008168522385.

9.

The growth factor inhibitor suramin reduces apoptosis and cell aggregation in protein-free CHO cell batch cultures.

Zanghi JA, Renner WA, Bailey JE, Fussenegger M.

Biotechnol Prog. 2000 May-Jun;16(3):319-25.

PMID:
10835230
10.

Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO(2) or pH.

Zanghi JA, Schmelzer AE, Mendoza TP, Knop RH, Miller WM.

Biotechnol Bioeng. 1999 Oct 20;65(2):182-91.

PMID:
10458739
11.
12.

Role of nucleotide sugar pools in the inhibition of NCAM polysialylation by ammonia.

Zanghi JA, Mendoza TP, Schmelzer AE, Knop RH, Miller WM.

Biotechnol Prog. 1998 Nov-Dec;14(6):834-44.

PMID:
9841644
13.

Ammonia inhibits neural cell adhesion molecule polysialylation in Chinese hamster ovary and small cell lung cancer cells.

Zanghi JA, Mendoza TP, Knop RH, Miller WM.

J Cell Physiol. 1998 Nov;177(2):248-63.

PMID:
9766522
14.

Discrimination of fluorinated uridine metabolites in N-417 small cell lung cancer cell extracts via 19F- and 31P-NMR.

Pederson NV, Zanghi JA, Miller WM, Knop RH.

Magn Reson Med. 1994 Feb;31(2):224-8.

PMID:
8133759
15.

Tools for decision making on capital expenditures.

Zanghi J.

J Healthc Mater Manage. 1992 Apr;10(3):22, 24, 26 passim.

PMID:
10117224

Supplemental Content

Loading ...
Support Center